Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials

Background - Patients’ reduced awareness of neurocognitive functioning (NCF) may negatively affect the reliability of patient-reported outcomes (PROs) and clinical decision-making. This study evaluated cognitive awareness, defined as the association between NCF and neurocognitive complaints, over th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Caramanna, Ivan (VerfasserIn) , Reijneveld, Jaap C. (VerfasserIn) , van de Ven, Peter M. (VerfasserIn) , van den Bent, Martin (VerfasserIn) , Idbaih, Ahmed (VerfasserIn) , Wick, Wolfgang (VerfasserIn) , Taphoorn, Martin J. B. (VerfasserIn) , Dirven, Linda (VerfasserIn) , Bottomley, Andrew (VerfasserIn) , Klein, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 March 2023
In: European journal of cancer
Year: 2023, Jahrgang: 186, Pages: 38-51
ISSN:1879-0852
DOI:10.1016/j.ejca.2023.02.029
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2023.02.029
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804923001259
Volltext
Verfasserangaben:Ivan Caramanna, Jaap C. Reijneveld, Peter M. van de Ven, Martin van den Bent, Ahmed Idbaih, Wolfgang Wick, Martin J. B. Taphoorn, Linda Dirven, Andrew Bottomley, Martin Klein

MARC

LEADER 00000caa a2200000 c 4500
001 1854651218
003 DE-627
005 20240329080212.0
007 cr uuu---uuuuu
008 230808s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2023.02.029  |2 doi 
035 |a (DE-627)1854651218 
035 |a (DE-599)KXP1854651218 
035 |a (OCoLC)1425213045 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Caramanna, Ivan  |e VerfasserIn  |0 (DE-588)1298783194  |0 (DE-627)1854651803  |4 aut 
245 1 0 |a Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma  |b Longitudinal evidence of cognitive awareness from EORTC brain tumour trials  |c Ivan Caramanna, Jaap C. Reijneveld, Peter M. van de Ven, Martin van den Bent, Ahmed Idbaih, Wolfgang Wick, Martin J. B. Taphoorn, Linda Dirven, Andrew Bottomley, Martin Klein 
264 1 |c 8 March 2023 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.08.2023 
520 |a Background - Patients’ reduced awareness of neurocognitive functioning (NCF) may negatively affect the reliability of patient-reported outcomes (PROs) and clinical decision-making. This study evaluated cognitive awareness, defined as the association between NCF and neurocognitive complaints, over the disease course of patients with recurrent high-grade glioma (HGG). - Methods - We assessed NCF using the EORTC core clinical trial battery and neurocognitive complaints using the Medical Outcome Study questionnaire. Patients were categorised as impaired or intact, based on their neurocognitive performance. Spearman’s rank correlations were calculated between NCF and neurocognitive complaints at baseline and each 12 weeks, until 36. The association between changes in NCF and neurocognitive complaints scores between these follow-up assessments was determined using Pearson’s correlation. - Results - A total of 546 patients were included. Neurocognitively impaired patients (n = 437) had more neurocognitive complaints (range: 10.51 [p < 0.001] to 13.34 [p = 0.001]) than intact patients (n = 109) at baseline, at 12 and 24 weeks. In intact patients, NCF and neurocognitive complaints were correlated for only one domain at baseline (0.202, p = 0.036), while in impaired patients correlations were more frequently found in various domains and time points (range: 0.164 [p = 0.001] to 0.334 [p = 0.011]). Over the disease course, NCF and neurocognitive complaints were correlated for only one domain at baseline (0.357, p = 0.014) in intact patients while in impaired patients they were correlated for more domains and time points (range: 0.222 [p < 0.001] to 0.366 [p < 0.001]). - Conclusion - Neurocognitively impaired patients with recurrent HGG are aware of their neurocognitive limitations at study entry and during follow-up, which should be considered in clinical decision-making and when interpreting PRO results. 
650 4 |a Cognitive awareness 
650 4 |a Glioma 
650 4 |a Neurocognitive complaints 
650 4 |a Neurocognitive functioning 
700 1 |a Reijneveld, Jaap C.  |e VerfasserIn  |4 aut 
700 1 |a van de Ven, Peter M.  |e VerfasserIn  |4 aut 
700 1 |a van den Bent, Martin  |e VerfasserIn  |4 aut 
700 1 |a Idbaih, Ahmed  |e VerfasserIn  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
700 1 |a Taphoorn, Martin J. B.  |e VerfasserIn  |4 aut 
700 1 |a Dirven, Linda  |e VerfasserIn  |4 aut 
700 1 |a Bottomley, Andrew  |e VerfasserIn  |4 aut 
700 1 |a Klein, Martin  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 186(2023), Seite 38-51  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma Longitudinal evidence of cognitive awareness from EORTC brain tumour trials 
773 1 8 |g volume:186  |g year:2023  |g pages:38-51  |g extent:14  |a Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma Longitudinal evidence of cognitive awareness from EORTC brain tumour trials 
856 4 0 |u https://doi.org/10.1016/j.ejca.2023.02.029  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0959804923001259  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230808 
993 |a Article 
994 |a 2023 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 6 
999 |a KXP-PPN1854651218  |e 4363855150 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Ivan Caramanna, Jaap C. Reijneveld, Peter M. van de Ven, Martin van den Bent, Ahmed Idbaih, Wolfgang Wick, Martin J. B. Taphoorn, Linda Dirven, Andrew Bottomley, Martin Klein"]},"id":{"doi":["10.1016/j.ejca.2023.02.029"],"eki":["1854651218"]},"recId":"1854651218","physDesc":[{"extent":"14 S."}],"relHost":[{"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb"}],"pubHistory":["28.1992 -"],"titleAlt":[{"title":"EJC online"}],"part":{"extent":"14","text":"186(2023), Seite 38-51","volume":"186","year":"2023","pages":"38-51"},"id":{"zdb":["1468190-0"],"issn":["1879-0852"],"eki":["266883400"]},"recId":"266883400","disp":"Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma Longitudinal evidence of cognitive awareness from EORTC brain tumour trialsEuropean journal of cancer","origin":[{"dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier ; Pergamon Press"}],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}]}],"person":[{"given":"Ivan","role":"aut","family":"Caramanna","display":"Caramanna, Ivan"},{"display":"Reijneveld, Jaap C.","given":"Jaap C.","role":"aut","family":"Reijneveld"},{"display":"van de Ven, Peter M.","family":"van de Ven","given":"Peter M.","role":"aut"},{"family":"van den Bent","role":"aut","given":"Martin","display":"van den Bent, Martin"},{"family":"Idbaih","role":"aut","given":"Ahmed","display":"Idbaih, Ahmed"},{"role":"aut","given":"Wolfgang","family":"Wick","display":"Wick, Wolfgang"},{"display":"Taphoorn, Martin J. B.","family":"Taphoorn","role":"aut","given":"Martin J. B."},{"role":"aut","given":"Linda","family":"Dirven","display":"Dirven, Linda"},{"display":"Bottomley, Andrew","given":"Andrew","role":"aut","family":"Bottomley"},{"display":"Klein, Martin","given":"Martin","role":"aut","family":"Klein"}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"8 March 2023"}],"title":[{"title_sort":"Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma","title":"Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma","subtitle":"Longitudinal evidence of cognitive awareness from EORTC brain tumour trials"}],"note":["Gesehen am 08.08.2023"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a CARAMANNAIASSOCIATIO8202